Search Results - "Frisoni, Giovanni B"

Exploring the Preventive Effects of Omega-3 Polyunsaturated Fatty Acids Supplementation on Global Cognition: A Systematic Review and Meta-Analysis of Cognitively Unimpaired Older Adults.

Authors: Mulargia, Roberta Ribaldi, Federica Mutel, Sophie et al.

Source: Clinical & Translational Neuroscience; Sep2025, Vol. 9 Issue 3, p34, 12p

Navigating the introduction of anti-amyloid therapy in Europe: a position statement by individual members of the EADC.

Authors: Frederiksen, Kristian S. Boada, Mercé Dubois, Bruno et al.

Source: Alzheimer's Research & Therapy. 5/24/2025, Vol. 17 Issue 1, p1-9. 9p.

Clinical and molecular correlates of limbic age-related TDP-43 encephalopathy (LATE) ¹⁸F-FDG-PET pattern in amnestic mild cognitive impairment.

Authors: Boccalini, Cecilia Knappe, Luisa Mathoux, Gregory et al.

Source: European Journal of Nuclear Medicine & Molecular Imaging. Nov2025, Vol. 52 Issue 13, p5075-5084. 10p.

[18F]flutemetamol uptake in the colon of a memory clinic population and its association with brain amyloidosis and the gut microbiota profile: an exploratory study.

Authors: Quattrini, Giulia Gatti, Elena Peretti, Débora Elisa et al.

Source: European Journal of Nuclear Medicine & Molecular Imaging. Oct2025, Vol. 52 Issue 12, p4591-4603. 13p.

The emerging field of non-invasive brain stimulation in Alzheimer's disease.

Authors: Koch, Giacomo Altomare, Daniele Benussi, Alberto et al.

Source: Brain: A Journal of Neurology; Dec2024, Vol. 147 Issue 12, p4003-4016, 14p

Association of glial fibrillary acid protein, Alzheimer's disease pathology and cognitive decline.

Authors: Peretti, Débora E Boccalini, Cecilia Ribaldi, Federica et al.

Source: Brain: A Journal of Neurology; Dec2024, Vol. 147 Issue 12, p4094-4104, 11p

Quantification Supports Amyloid PET Visual Assessment of Challenging Cases: Results from the AMYPAD Diagnostic and Patient Management Study.

Authors: Collij, Lyduine E. Bischof, Gérard N. Altomare, Daniele et al.

Source: Journal of Nuclear Medicine. Jan2025, Vol. 66 Issue 1, p110-116. 7p.

Clinical versus biomarker-based diagnosis of neurocognitive disorders – Authors' reply.

Authors: Massa, Federico Villain, Nicolas Cotta Ramusino, Matteo et al.

Source: Lancet Neurology. Aug2024, Vol. 23 Issue 8, p766-767. 2p.

Gut microbiome signatures in iNPH: Insights from a shotgun metagenomics study.

Authors: Park, Rahel Chevalier, Claire Kieser, Silas et al.

Source: PLoS ONE. 9/15/2025, Vol. 20 Issue 9, p1-17. 17p.

Dementia risk estimation in persons at risk and the predictive turn in Alzheimer's disease—The PreTAD project: Study protocol with an ethical, clinical, linguistic, and legal approach.

Authors: Gerards, Michelle Baumeister, Annika Hübner, Constanze et al.

Source: PLoS ONE. 7/16/2025, Vol. 20 Issue 7, p1-19. 19p.

Amyloid-PET imaging predicts functional decline in clinically normal individuals.

Authors: Quenon, Lisa Collij, Lyduine E. Garcia, David Vállez et al.

Source: Alzheimer's Research & Therapy. 6/17/2024, Vol. 16 Issue 1, p1-13. 13p.

Early-phase ¹⁸F-Flortaucipir tau-PET as a proxy of brain metabolism in Alzheimer's disease: a comparison with ¹⁸F-FDG-PET and early-phase amyloid-PET.

Authors: Boccalini, Cecilia Peretti, Debora Elisa Mathoux, Gregory et al.

Source: European Journal of Nuclear Medicine & Molecular Imaging. May2025, Vol. 52 Issue 6, p1958-1969. 12p.

A visual scale to rate amygdalar atrophy on MRI.

Authors: Pizzini, Francesca B. Ribaldi, Federica Natale, Valerio et al.

Source: European Radiology. Jul2025, Vol. 35 Issue 7, p4246-4256. 11p.

Subjects: Amygdaloid body, Neurodegeneration, Cerebral atrophy, TDP-43 proteinopathies, Statistical reliability, Metrology, Magnetic resonance imaging, Diagnostic services

Neuroimaging-guided diagnosis of possible FTLD-FUS pathology: a case report.

Authors: Mathoux, Gregory Boccalini, Cecilia Lathuliere, Aurelien et al.

Source: EJNMMI Research. 4/4/2024, Vol. 14 Issue 1, p1-5. 5p.

Sex differences in the association of Alzheimer's disease biomarkers and cognition in a multicenter memory clinic study.

Authors: Boccalini, Cecilia Peretti, Debora Elisa Scheffler, Max et al.

Source: Alzheimer's Research & Therapy. 2/18/2025, Vol. 17 Issue 1, p1-11. 11p.

Fecal Microbiota Transplantation (FMT) From a Human at Low Risk for Alzheimer's Disease Improves Short‐Term Recognition Memory and Increases Neuroinflammation in a 3xTg AD Mouse Model.

Authors: Chevalier, Claire Tournier, Benjamin B. Marizzoni, Moira et al.

Source: Genes, Brain & Behavior. Feb2025, Vol. 24 Issue 1, p1-10. 10p.

Caregiver's Distress Is Associated With Delusions in Alzheimer's Patients.

Authors: Riello, Roberta Geroldi, Cristina Zanetti, Orazio et al.

Source: Behavioral Medicine. Fall2002, Vol. 28 Issue 3, p92. 7p. 1 Diagram.

Subjects: Alzheimer's disease, Presenile dementia, Caregivers, Dementia, Brain diseases

Alzheimer-Krankheit -- Systembereitschaft im Kontext neuer Entwicklungen.

Alternate Title: Alzheimer's disease -- system prepardeness in the context of new developments.

Authors: Meyer, Rafael Monsch, Andreas Allali, Gilles et al.

Source: Praxis (1661-8157). dec2024, Vol. 113 Issue 11/12, p293-296. 4p.

Citrus supplementation in subjective cognitive decline: results of a 36-week, randomized, placebo-controlled trial.

Authors: Galluzzi, Samantha Marizzoni, Moira Gatti, Elena et al.

Source: Nutrition Journal. 10/31/2024, Vol. 23 Issue 1, p1-11. 11p.

A deep learning model for generating [¹⁸F]FDG PET Images from early-phase [¹⁸F]Florbetapir and [¹⁸F]Flutemetamol PET images.

Authors: Sanaat, Amirhossein Boccalini, Cecilia Mathoux, Gregory et al.

Source: European Journal of Nuclear Medicine & Molecular Imaging. Oct2024, Vol. 51 Issue 12, p3518-3531. 14p.